Willard H Dere is Director of Mersana Therapeutics, Inc.. Currently has a direct ownership of 39,182 shares of MRSN, which is worth approximately $62,691. The most recent transaction as insider was on Jan 02, 2024, when has been sold 6,112 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 39.2K
0% 3M change
18.48% 12M change
Total Value Held $62,691

Willard H Dere Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jan 02 2024
BUY
Grant, award, or other acquisition
-
6,112 Added 13.49%
39,182 Common Stock
Oct 02 2023
BUY
Grant, award, or other acquisition
-
11,011 Added 24.98%
33,070 Common Stock
Jul 03 2023
BUY
Grant, award, or other acquisition
-
4,217 Added 16.05%
22,059 Common Stock
Jun 08 2023
BUY
Grant, award, or other acquisition
-
14,467 Added 44.78%
17,842 Common Stock
Apr 03 2023
BUY
Grant, award, or other acquisition
-
3,375 Added 50.0%
3,375 Common Stock

Also insider at

RDUS
Radius Health, Inc. Healthcare
BMRN
BIOMARIN PHARMACEUTICAL INC Healthcare
MCRB
Seres Therapeutics, Inc. Healthcare
MGX
Metagenomi, Inc.
WHD

Willard H Dere

Director
Cambridge, MA

Track Institutional and Insider Activities on MRSN

Follow Mersana Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells MRSN shares.

Notify only if

Insider Trading

Get notified when an Mersana Therapeutics, Inc. insider buys or sells MRSN shares.

Notify only if

News

Receive news related to Mersana Therapeutics, Inc.

Track Activities on MRSN